ambamustine has been researched along with Leukemia L 1210 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bekesi, JG; Yagi, MJ | 2 |
Bekesi, JG; Holland, JF; Yagi, MJ; Zanjani, M | 1 |
Bekesi, JG; Chin, SE; Holland, JF; Scanlon, KJ; Yagi, MJ | 2 |
5 other study(ies) available for ambamustine and Leukemia L 1210
Article | Year |
---|---|
Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Leukemia L1210; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Nitrogen Mustard Compounds | 1983 |
Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.
Topics: Animals; Cell Survival; Cells, Cultured; Female; Leukemia L1210; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitrogen Mustard Compounds | 1984 |
Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Female; Leukemia; Leukemia L1210; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Nitrogen Mustard Compounds; Osteosarcoma; Remission Induction | 1990 |
Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
Topics: Alkylating Agents; Amino Acids; Animals; Biological Transport, Active; Leukemia L1210; Melphalan; Nitrogen Mustard Compounds; Sodium; Tumor Cells, Cultured | 1988 |
PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance; Leukemia L1210; Melphalan; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1985 |